Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 499

1.

Evaluating the evidence on comparative effectiveness and value of management options for treatment-resistant depression.

Emond SK, Ollendorf DA, Colby JA, Reed SJ, Pearson SD.

Postgrad Med. 2013 Nov;125(6):7-16. doi: 10.3810/pgm.2013.11.2707.

PMID:
24200756
[PubMed - indexed for MEDLINE]
2.

Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication.

Toups MS, Myers AK, Wisniewski SR, Kurian B, Morris DW, Rush AJ, Fava M, Trivedi MH.

Psychosom Med. 2013 Nov-Dec;75(9):863-72. doi: 10.1097/PSY.0000000000000000. Epub 2013 Oct 25.

PMID:
24163386
[PubMed - indexed for MEDLINE]
3.

Challenging sequential approach to treatment resistant depression: cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STAR(⁎)D) trial.

Olgiati P, Bajo E, Bigelli M, Montgomery S, Serretti A; C.E.A.P (Cost-Effectiveness Analysis on Psychiatric Disorders)-group.

Eur Neuropsychopharmacol. 2013 Dec;23(12):1739-46. doi: 10.1016/j.euroneuro.2013.08.008. Epub 2013 Sep 13.

PMID:
24075716
[PubMed - indexed for MEDLINE]
Free Article
4.

Augmentation of aripiprazole for depressed patients with an inadequate response to antidepressant treatment: a 6-week prospective, open-label, multicenter study.

Jon DI, Kim do H, Seo HJ, Kwon YJ, Kim MD, Yang JC, Suh HS, Min KJ, Pae CU, Bahk WM.

Clin Neuropharmacol. 2013 Sep-Oct;36(5):157-61. doi: 10.1097/WNF.0b013e3182a31f3d.

PMID:
24045606
[PubMed - indexed for MEDLINE]
5.

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ.

Am J Psychiatry. 2013 Oct 1;170(10):1134-42. doi: 10.1176/appi.ajp.2013.13030392.

PMID:
23982301
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.

Cusin C, Iovieno N, Iosifescu DV, Nierenberg AA, Fava M, Rush AJ, Perlis RH.

J Clin Psychiatry. 2013 Jul;74(7):e636-41. doi: 10.4088/JCP.12m08093.

PMID:
23945458
[PubMed - indexed for MEDLINE]
7.

Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout.

Rutherford BR, Cooper TM, Persaud A, Brown PJ, Sneed JR, Roose SP.

J Clin Psychiatry. 2013 Jul;74(7):703-15. doi: 10.4088/JCP.12r08267.

PMID:
23945448
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial.

Cipriani A, Girlanda F, Agrimi E, Barichello A, Beneduce R, Bighelli I, Bisoffi G, Bisogno A, Bortolaso P, Boso M, Calandra C, Cascone L, Corbascio C, Parise VF, Gardellin F, Gennaro D, Hanife B, Lintas C, Lorusso M, Luchetta C, Lucii C, Cernuto F, Tozzi F, Marsilio A, Maio F, Mattei C, Moretti D, Appino MG, Nosè M, Occhionero G, Papanti D, Pecile D, Purgato M, Prestia D, Restaino F, Sciarma T, Ruberto A, Strizzolo S, Tamborini S, Todarello O, Ziero S, Zotos S, Barbui C.

BMC Psychiatry. 2013 Aug 13;13:212. doi: 10.1186/1471-244X-13-212.

PMID:
23941474
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Impaired prefronto-thalamic functional connectivity as a key feature of treatment-resistant depression: a combined MEG, PET and rTMS study.

Li CT, Chen LF, Tu PC, Wang SJ, Chen MH, Su TP, Hsieh JC.

PLoS One. 2013 Aug 2;8(8):e70089. doi: 10.1371/journal.pone.0070089. Print 2013.

PMID:
23936378
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Antidepressant and neurocognitive effects of isoflurane anesthesia versus electroconvulsive therapy in refractory depression.

Weeks HR 3rd, Tadler SC, Smith KW, Iacob E, Saccoman M, White AT, Landvatter JD, Chelune GJ, Suchy Y, Clark E, Cahalan MK, Bushnell L, Sakata D, Light AR, Light KC.

PLoS One. 2013 Jul 26;8(7):e69809. doi: 10.1371/journal.pone.0069809. Print 2013.

PMID:
23922809
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Repeated S-ketamine infusions in therapy resistant depression: a case series.

Segmiller F, Rüther T, Linhardt A, Padberg F, Berger M, Pogarell O, Möller HJ, Kohler C, Schüle C.

J Clin Pharmacol. 2013 Sep;53(9):996-8. doi: 10.1002/jcph.122. Epub 2013 Jul 24. No abstract available.

PMID:
23893490
[PubMed - indexed for MEDLINE]
12.

[Treatment of refractory depression patients of yin deficiency inner heat syndrome by jieyu granule combined paroxetine: an efficacy observation].

Liu J, Jia HX, Wang JQ, Xu Y, Tian JZ, Shi J.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Apr;33(4):462-5. Chinese.

PMID:
23841263
[PubMed - indexed for MEDLINE]
13.

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.

Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA.

J Affect Disord. 2013 Oct;151(1):209-19. doi: 10.1016/j.jad.2013.05.079. Epub 2013 Jun 27.

PMID:
23810357
[PubMed - indexed for MEDLINE]
14.

Interaction of valproic acid and amitriptyline: analysis of therapeutic drug monitoring data under naturalistic conditions.

Unterecker S, Burger R, Hohage A, Deckert J, Pfuhlmann B.

J Clin Psychopharmacol. 2013 Aug;33(4):561-4. doi: 10.1097/JCP.0b013e3182905d42.

PMID:
23775047
[PubMed - indexed for MEDLINE]
15.

The effects of stimulation parameters on clinical outcomes in patients with vagus nerve stimulation implants with major depression.

Müller HH, Kornhuber J, Maler JM, Sperling W.

J ECT. 2013 Sep;29(3):e40-2. doi: 10.1097/YCT.0b013e318290f7ed.

PMID:
23728236
[PubMed - indexed for MEDLINE]
16.

Personality traits as risk factors for treatment-resistant depression.

Takahashi M, Shirayama Y, Muneoka K, Suzuki M, Sato K, Hashimoto K.

PLoS One. 2013 May 22;8(5):e63756. doi: 10.1371/journal.pone.0063756. Print 2013.

PMID:
23717477
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Tianeptine combination for partial or non-response to selective serotonin re-uptake inhibitor monotherapy.

Woo YS, Bahk WM, Jeong JH, Lee SH, Sung HM, Pae CU, Koo BH, Kim W.

Psychiatry Clin Neurosci. 2013 May;67(4):219-27. doi: 10.1111/pcn.12042.

PMID:
23683152
[PubMed - indexed for MEDLINE]
18.

rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: effectiveness and effects of age.

Ciobanu C, Girard M, Marin B, Labrunie A, Malauzat D.

J Affect Disord. 2013 Sep 5;150(2):677-81. doi: 10.1016/j.jad.2013.03.024. Epub 2013 May 11.

PMID:
23673085
[PubMed - indexed for MEDLINE]
19.

Possible usefulness of tianeptine in treatment-resistant depression.

Tobe EH, Rybakowski JK.

Int J Psychiatry Clin Pract. 2013 Oct;17(4):313-6. doi: 10.3109/13651501.2013.798418. Epub 2013 May 20.

PMID:
23668804
[PubMed - indexed for MEDLINE]
20.

Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.

Palm U, Fintescu Z, Obermeier M, Schiller C, Reisinger E, Keeser D, Pogarell O, Bondy B, Zill P, Padberg F.

J Affect Disord. 2013 Sep 5;150(2):659-63. doi: 10.1016/j.jad.2013.03.015. Epub 2013 May 7.

PMID:
23664268
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk